Paladin Capital Group
Paladin Capital Group is a leading multi-stage private equity firm that provides funding to growing companies. Across the globe, from Silicon Valley to Brazil, we invest in best-of-breed companies with technologies, products, and services that meet the challenging demands of commercial, federal, and international customers. Paladin has over $950 million of committed capital invested across multiple funds.
Prolog provides venture capital to Healthy Living entrepreneurs. We share their passion for wellbeing of individuals, communities, and the environment. We back innovations enhancing the quality of life and offering better ways to monitor it. Prolog principals are experienced investors and business builders, with a long history of collaboration and a track record at four Prolog and several prior VC funds. Collectively, those funds secured in excess of $500 million in capital commitments and partnered with over 100 companies.
Vital Venture Capital LLC
Vital Venture Capital, formed in 2008 with offices in MD and CT, makes multi-stage investments in companies within fast-growing proprietary life sciences and un-penetrated enterprise software sectors with competitive barriers. The firm invests throughout the United States and Canada. Vital focuses on investments in intellectual property-intensive companies that have significant patent protection or other proprietary value. Vital has made investments in 18 portfolio companies with 2 successful exits to date and has a very strongly performing portfolio.
Alafi Capital is a private venture capital firm that has been active in healthcare investing for over 25 years. Early and mid-stage investments in the U.S. and Europe are considered, with emphasis on product-oriented biotechnology, life science technologies, imaging and diagnostics, and medical devices.
Included among Alafi Capital’s past successes are Amgen, Biogen, Molecular Devices, Tanox, Qiagen, Novocor, Oxford Glycosciences, and Applied
Correlation Ventures is a new breed of venture capital firm, leveraging world-class analytics to offer entrepreneurs and other venture capitalists a dramatically better option when they are seeking additional capital to complete a financing round. Backed by leading institutional investors, Correlation has more than $165 million under management.